4hon MSN
When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...
A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...
Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.
22h
Hosted on MSNResearchers Uncover Genomic Drivers Behind Aggressive Breast CancerBreast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...
34m
News Medical on MSNDual-target drug may lead to new treatment approach for breast cancer patientsResearchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...
22hon MSN
Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...
The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.
22h
Verywell Health on MSN10 Tips for Living With Early-Stage HER2-Positive Breast CancerHER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...
A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...
KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...
16h
News Medical on MSNMachine learning tool predicts cancer treatment response based on genetic mutationsA groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes-insights that could help doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results